Liraglutide reduces lipogenetic signals in visceral adipose of db/db mice with AMPK activation and Akt suppression.
about
EJE PRIZE 2017: Hypothalamic AMPK: a golden target against obesity?Protection against cardiac hypertrophy by geniposide involves the GLP-1 receptor / AMPKα signalling pathwayTargeting adipose tissue in the treatment of obesity-associated diabetes.Drugs Involved in Dyslipidemia and Obesity Treatment: Focus on Adipose Tissue.Disrupted sphingolipid metabolism following acute clozapine and olanzapine administration.
P2860
Liraglutide reduces lipogenetic signals in visceral adipose of db/db mice with AMPK activation and Akt suppression.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Liraglutide reduces lipogeneti ...... ctivation and Akt suppression.
@en
Liraglutide reduces lipogeneti ...... ctivation and Akt suppression.
@nl
type
label
Liraglutide reduces lipogeneti ...... ctivation and Akt suppression.
@en
Liraglutide reduces lipogeneti ...... ctivation and Akt suppression.
@nl
prefLabel
Liraglutide reduces lipogeneti ...... ctivation and Akt suppression.
@en
Liraglutide reduces lipogeneti ...... ctivation and Akt suppression.
@nl
P2093
P2860
P356
P1476
Liraglutide reduces lipogeneti ...... ctivation and Akt suppression.
@en
P2093
Geheng Yuan
Junqing Zhang
Xiaohui Guo
Yimin Shao
P2860
P304
P356
10.2147/DDDT.S79175
P407
P577
2015-02-18T00:00:00Z